Ministry of Health survey improves understanding of epilepsy

Media Release

Ministry of Health survey improves understanding of epilepsy

26 March 2018

The Ministry of Health recognises the challenges that people living with epilepsy face and is working to understand the condition better.

To help raise awareness of epilepsy and mark Epilepsy New Zealand’s ‘Purple Day’ campaign, the Ministry of Health is releasing the findings of its first Epilepsy Consumer Experience Survey today.

The Ministry surveyed 276 people living with epilepsy, to understand more about their experiences with health services, support services, and in their community, school and employment situations.

“Understanding the challenges, needs and priorities of people with epilepsy, what services are working well and where we can improve, is critical to helping improve the services we provide,” says Ministry of Health group manager District Health Board (DHB) performance and support Sam Kunowski.

Epilepsy is a condition defined by recurring epileptic seizures that arise due to abnormal electrical activity in the brain. There are many causes of epilepsy and many types of seizures that can be experienced. Children and the elderly are more likely to be diagnosed with epilepsy than other age groups. Approximately 60 people die from an epilepsy-related cause each year.

“In New Zealand, approximately 40 to 50 thousand people are affected by epilepsy, with approximately 2,000 new diagnoses each year,” says Mr Kunowski. “People with epilepsy are high users of health and social services. Yet there is limited understanding of how the condition affects those living with it, or their families and whanau.”

"Some common experiences and issues highlighted by the survey included social challenges, anxiety or depression, physical injury, social isolation and being unable to drive for periods of time."

“We want to use the survey information to guide aspects of our epilepsy service model and improvement action plan. We want all people with epilepsy to live well and have access to high quality, people-centred care that is integrated across hospital and community settings,” says Mr Kunowski.

The next Epilepsy Consumer Experience survey will be conducted in three years time.

The Epilepsy Consumer Experience Survey is available to view on the Ministry of Health's website:

Media contact
Lucy Hall
021 598 485


Prev   Next 

Latest Updates

  • Covid 19 and Epilepsy Update 26 March 2020
    26 March 2020

    Epilepsy New Zealand has been receiving regular information from the Ministry of Health and other agencies, often more than once a day, showing just how quickly the situation is evolving. No doubt there will be many people, including those with epilepsy, who have questions around their risk and what to do in these uncertain times. Hopefully the information below may help reassure you and where necessary, prompt you to contact your trusted health professional.

  • BPAC issues new guidelines for Lamotrigine
    26 September 2019

    BPAC issues new guidelines for Lamotrigine.

  • Petition against Pharmac's drug changes
    29 August 2019

    A petition is underway calling on Pharmac to reverse its decision on Lamotrigine.

  • Epilepsy NZ Position Statement - Lamotrigine
    28 August 2019

    We opposed this change from Lamictal to Logem from the start, and staff have advocated on behalf of people with epilepsy in discussions with Pharmac.

  • Don't Give Up by Adele Hauwai
    4 December 2017

    Adele Hauwai has shared her Living With Epilepsy story as part of the Epilepsy NZ Tell Us About It Competition. People were asked to send in their stories about epilepsy, the challenges they faced and the lessons they have learned that they would like to share with the world.

  • New ILAE Seizure Classification
    10 March 2017

    The ILAE announces the publication in Epilepsia of two new landmark classification documents, one of seizure types and one of the epilepsies.

Show Your Support

Shop Online

Epilepsy NZ has an online shop!


Donate Today